5709 results for "canc*"

in 29.88 milliseconds.

• NKI (Netherlands Cancer Institute)

  Dac EGAC00001001648

• Spatial Characterization Breast Cancer

  Dac EGAC00001001673

• Zero Childhood Cancer

  Dac EGAC00001001683

• Primary tumor and metastatic breast cancer data access

  Dac EGAC00001001687

• DAC for Stuttgart Breast Cancer Cohort

  Dac EGAC00001001693

• Detection of ctDNA in Plasma of Patients with Clinically Localised Prostate Cancer is Associated with Rapid Disease Progression

  Dac EGAC00001001718

• Gene expression and Cancer

  Dac EGAC00001001727

• MyBrCa Tumour Genomics DAC

  Dac EGAC00001001740

• Lung cancer TRM Data Access Commitee

  Dac EGAC00001001759

• Cancer Research UK manchester Institute Cancer Biomarker Centre

  Dac EGAC00001001765

• Gene expression and Cancer

  Dac EGAC00001001772

• Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital

  Dac EGAC00001001774

• Access to aligned sequencing data for study "Loss of SNAI2 in prostate cancer correlates with clinical response to androgen deprivation therapy".

  Dac EGAC00001001809

• Imperial College Tumour Immunology group - Surgery and Cancer DAC

  Dac EGAC00001001814

• Long-read isoform in breast cancer - Data Access Commitee

  Dac EGAC00001001821

• AGECAN - DAC (Interespecies conservation of brain specific DNA methylation in aging and cancer)

  Dac EGAC00001001840

• PBL Cancer Data Committee

  Dac EGAC00001001870

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001906

• Division of Cellular Signaling National Cancer Center Research Institute

  Dac EGAC00001001909

• bladder cancer data access commitee

  Dac EGAC00001002016

• Data access committee for lung cancer

  Dac EGAC00001001942

• 4C Ovarian Cancer Data Access Committee

  Dac EGAC00001001953

• Singapore Gastric Cancer Consortium Data Access Committee

  Dac EGAC00001001955

• 4C Endometrial Cancer Data Access Committee

  Dac EGAC00001001956

• HER2-negative primary breast cancers WES

  Dac EGAC00001001973

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001001974

• BCRC-ICGS (Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, Univ. of Birmingham) Data Access Committee

  Dac EGAC00001001982

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001988

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001002007

• Whole Exome Sequencing of Mixed Histology Lung Cancer at MDACC

  Dac EGAC00001002034

• Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital

  Dac EGAC00001002086

• Charbonneau Cancer Institute DAC

  Dac EGAC00001002096

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002160

• AA/UTUC Cancer Data Access Commitee

  Dac EGAC00001002162

• MRC Institute of Genetics and Cancer Data Access Committee

  Dac EGAC00001002163

• University of Calgary Charbonneau Cancer Institute

  Dac EGAC00001002170

• The data access committee for Detection and characterization of lung cancer using cell-free DNA fragmentomes

  Dac EGAC00001002184

• TCRseq in cancers DAC

  Dac EGAC00001002235

• Cancer Proteomics Mass Spectrometry group

  Dac EGAC00001002236

• CRMY team data access committee

  Dac EGAC00001002249

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002388

• The MITIMM Cancer Data Access Committee

  Dac EGAC00001002268

• Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

  Dac EGAC00001002276

• Data access committee breast cancer whole genome sequencing HRD

  Dac EGAC00001002286

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002291

• Genomics to select patients with metastatic breast cancer for targeted therapy DAC

  Dac EGAC00001002293

• RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors

  Dac EGAC00001002295

• EPICC: Evolutionary Predictions in Colorectal Cancer

  Dac EGAC00001002299

• OV cancer cell lines DAC

  Dac EGAC00001002307

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001002331

• MDACC Breast Cancer MoonShot Data Access Committee

  Dac EGAC00001002362

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002387

• Somatic pathogenic variants in the normal mammary gland of sporadic breast cancer patients.

  Dac EGAC00001002391

• Leeds institute of Medical Research Bladder Cancer Research Group

  Dac EGAC00001002397

• Cancer Clinical Research Trust DAC for the 23 WES samples of melanoma subtypes

  Dac EGAC00001002402

• University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee

  Dac EGAC00001002442

• Cancer Team Data Access Committee

  Dac EGAC00001002449

• Netherlands Cancer Institute - Breast Cancer Neoadjuvant chemotherapy biomarker studies

  Dac EGAC00001002452

• Cancer Sequencing Data Access Committee

  Dac EGAC00001002457

• Cancer Core Europe Data Access Commitee

  Dac EGAC00001002460

• Data Access Committee for the study "Somatic chronology of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing"

  Dac EGAC00001002479

• Whole-exome sequencing of 47 microsatellites stable Early-onset sporadic rectal cancer (EOSRC) tumors and corresponding normal samples.

  Dac EGAC00001002502

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002508

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001002510

• DAC of The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals

  Dac EGAC00001002517

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002520

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002526

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002535

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002541

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002546

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002554

• GIS - NCCS Pancreatic Cancer DAC

  Dac EGAC00001002565

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002580

• Prostate Cancer Sample Data Access Commitee

  Dac EGAC00001002586

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002587

• EPICC: Evolutionary Predictions in Colorectal Cancer

  Dac EGAC00001002592

• Prostate Cancer Sample Data Access Commitee

  Dac EGAC00001002593

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002608

• Netherlands Cancer Institute (NKI) - Wilbert Zwart Group

  Dac EGAC00001002618

• DAC for Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

  Dac EGAC00001002644

• UCL cancer institute data access commitee

  Dac EGAC00001002659

• Salivary gland cancer TSO500 data team

  Dac EGAC00001002668

• Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR

  Dac EGAC00001002669

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002691

• Computational Cancer Genomics and Tumor Evolution Group

  Dac EGAC00001002722

• MSKCC Colorectal Cancer Plasma WGS Data Access Comittee

  Dac EGAC00001002741

• Netherlands Cancer Institute (NKI) - Jos Jonkers Group

  Dac EGAC00001002749

• Southern African Prostate Cancer Study (SAPCS) Data Access Committee

  Dac EGAC00001002768

• Garvan/St Vincent’s Prostate Cancer Tissue and Data Access Committee

  Dac EGAC00001002769

• Breast cancer bone metastases

  Dac EGAC00001002771

• Breast cancer bone metastases

  Dac EGAC00001002772

• Netherlands Cancer Institute (NKI) - Wilbert Zwart Group

  Dac EGAC00001002782

• DAC Synergie Lyon Cancer

  Dac EGAC00001002795

• Colorectal cancer samples

  Dac EGAC00001002808

• RNAseq analysis on metastatic Colorectal Cancer xenografts samples

  Dac EGAC00001002809

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001002829

• Netherlands Cancer Institute (NKI) - Jos Jonkers Group

  Dac EGAC00001002848

• Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures

  Dac EGAC00001002865

• Cancers of Unknown Primary

  Dac EGAC00001002878

• Cancer Team Data Access Committee

  Dac EGAC00001002891